期刊文献+

胰腺导管内乳头状黏液性肿瘤的研究进展 被引量:1

Advances in studies on intraductal papillary mucinous neoplasms of the pancreas
下载PDF
导出
摘要 胰腺导管内乳头状黏液性肿瘤(IPMNs)是常见的胰腺囊性肿瘤。IPMNs以胰腺导管内上皮乳头样增生及分泌大量粘蛋白为特点。一般根据不同的位置分为主胰管型、分支胰管型、混合型。近年对IPMNs的流行病学、病理特征、诊断、处理原则等方面均有了新的认识。本文就IPMNs的研究进展作一综述。 Cystic pancreatic neoplasms are increasingly recognized,with intraductal papillary mucinous neoplasms of the pancreas(IPMNs) being the most frequently type. IPMNs are characterized by mucin production and epithelial growth within the pancreatic duets, and are generally differentiated according to location:main pancreatic duet, its ma- jor side branches, or mixed type. Recently new knowledge of its epidemiology, pathological, characteristics, diagnosis and management has been emerged. This article reviewed the advances in the study on IPMNs.
出处 《现代肿瘤医学》 CAS 2014年第3期701-703,共3页 Journal of Modern Oncology
基金 黑龙江省自然科学基金资助项目(编号:H201373) 佳木斯大学青年基金资助项目(编号:Sq2013-024) 黑龙江省卫生厅项目(编号:2013-238)
关键词 胰腺导管内乳头状黏液性肿瘤 诊断 治疗 intraductal papillary mucinous neoplaslns of the pancreas diagnosis treatment
  • 相关文献

参考文献4

二级参考文献78

  • 1王单松,靳大勇,楼文晖,许雪峰,匡天涛,倪晓凌,吴文川,纪元.胰腺囊性肿瘤26例临床诊治分析[J].中国实用外科杂志,2005,25(11):681-683. 被引量:26
  • 2Sohail MA,Saif MW.Role of anticoagulation in the management of pancreatic cancer.JOP,2009,10:82-87.
  • 3Riess H,Pelzer U,Deutschinoff G,et al.A prospective,randomized trial of chemotherapy with or without the low molecular weight heparin enoxaparin in patients with advanced pancreatic cancer:Results of the CONKO 004 trial.J Clin Oncol,2009,27:4506.
  • 4Riess H,Pelzer U,Hilbig A,et al.Rationale and design of PROSPECT-CONKO 004:a prospective,randomized trial of simultaneous pancreatic cancer treatment with enoxaparin and chemotherapy.BMC Cancer,2008,8:361.
  • 5Burris HA 3rd,Moore MJ,Andersen J,et al.Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer:a randomized trial.J Clin Oncol,1997,15:2403-2413.
  • 6Heinemann V,Labianca R,Hinke A,et al.Increased survival using platinum analog combined with gemcitabine as compared to single-agent gemcitabine in advanced pancreatic cancer:pooled analysis of two randomized trials,the GERCOR/GISCAD intergroup study and a German multicenter study.Ann Oncol,2007,18:1652-1659.
  • 7Heinemann V,Boeck S,Hinke A,et al.Meta-analysis of randomized trials:evaluation of benefit from gemcitabine-based combination chemotherapy applied in advanced pancreatic cancer.BMC Cancer,2008,8:82.
  • 8Colucci G,Labianca R,Di Costanzo F,et al.A randomized trial of gemcitabine (G) versus G plus cisplatin in chemotherapy-naive advanced pancreatic adenocarcinoma:The GIP-1 (Gruppo Italiano Pancreas-GOIM/GISCAD/GOIRC) study.J Clin Oncol,2009,27:4504.
  • 9Bernhardt SL,Gjertsen MK,Trachsel S,et al.Telomerase peptide vaccination of patients with non-resectable pancreatic cancer:A dose escalating phase Ⅰ / Ⅱ study.Br J Cancer,2006,95:1474-1482.
  • 10Buanes T,Maurel J,Liauw W,et al.A randomized phase Ⅲ study of gemcitabine (G) versus GV1001 in sequential combination with G in patients with unresectable and metastatic pancreatic cancer.J Clin Oncol,2009,27:4601.

共引文献29

同被引文献1

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部